Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.94
+0.36 (2.47%)
At close: Jun 26, 2026, 4:00 PM EDT
14.56
-0.38 (-2.53%)
After-hours: Jun 26, 2026, 6:21 PM EDT
Janux Therapeutics Employees
Janux Therapeutics had 108 employees as of March 31, 2026. The number of employees decreased by 1 or -0.92% since the number was last reported on December 31, 2025.
Employees
108
Change
-1
Growth
-0.92%
Revenue / Employee
$127,157
Profits / Employee
-$1,059,981
Market Cap
911.11M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Solid Biosciences | 121 |
| Odyssey Therapeutics | 100 |
| Annexon | 93 |
| Theravance Biopharma | 90 |
| Vor Biopharma | 76 |
| Alto Neuroscience | 68 |
| Avalo Therapeutics | 33 |
JANX News
- 2 days ago - Janux Therapeutics assumed with a Buy at Truist - TheFly
- 3 days ago - Janux Therapeutics reports departure of Chief Medical Officer - TheFly
- 6 weeks ago - Janux Therapeutics price target lowered to $22 from $23 at Evercore ISI - TheFly
- 7 weeks ago - Janux Therapeutics price target lowered to $36 from $45 at Wedbush - TheFly
- 7 weeks ago - Janux Therapeutics price target lowered to $26 from $30 at Piper Sandler - TheFly
- 7 weeks ago - Janux Therapeutics reports Q1 EPS (39c), consensus (52c) - TheFly
- 7 weeks ago - Janux Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
- 7 weeks ago - Janux Therapeutics Earnings release: Q1 2026 - Filings